scholarly journals Cost‐Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis

2019 ◽  
Vol 71 (7) ◽  
pp. 855-864 ◽  
Author(s):  
Elena Losina ◽  
Karen C. Smith ◽  
A. David Paltiel ◽  
Jamie E. Collins ◽  
Lisa G. Suter ◽  
...  
2019 ◽  
Vol 2 (1) ◽  
pp. 26-36 ◽  
Author(s):  
Karen C. Smith ◽  
Elena Losina ◽  
Stephen P. Messier ◽  
David J. Hunter ◽  
Angela T. Chen ◽  
...  

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 923.4-924
Author(s):  
H. Hachfi ◽  
D. Khalifa ◽  
M. Brahem ◽  
N. Ben Chekaya ◽  
M. Younes

Background:Knee osteoarthritis and obesity are both major health problems. It is now admitted that the prevalence of knee osteoarthritis gets higher with obesity and that weight loss helps knee function and allows patients to avoid surgery.Objectives:The aim of this study was to study the influence of obesity on knee osteoarthritis features.Methods:A cross-sectional study was conducted in the university hospital Taher Sfar of Tunisia over a period of 6 months. Patients who had knee osteoarthritis confirmed by radiographs were included. Sociodemographic, clinical, radiological and therapeutic data were collected from medical records and visits. Obesity was defined by a body mass index (BMI) ≥30. Functional impairment was assessed by the Womac index and Lequesne index.Results:The study included 186 patients. There were 31 males and 155 femmes. The mean age was 60±10 years. The percentage of obese patients was 53,8%. The mean age was similar in both groups obese and non obese. There were more women in the obese group compared to the non obese group (p=0.0001), more patients who had diabetes mellitus and dyslipidemia (p=0.002). Non-obese patients had a shorter duration of symptoms with no statistical significance (p=0.151). Obese patients had more involvement of both knees (p<0.0001). Obesity did not have an impact on pain severity. Severity of radiological images (p=0,0001) were more frequent in obese patients. Functional impairment was similar in both groups. However, the percentage of patients having a very important functional impairment with Lequesne index was higher in obese patients (p<0.029). Obese patients also needed more physical therapy sessions (p=0.035).Conclusion:Knee osteoarthritis in obese patients is characterized with the femlae gender predominance, bilateral knee involvement, and a more severe images on radiographs. Thus the need for better control of weight and the importance of physical activity.References:[1]Coggon D, Reading I, Croft P, et al. Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord J Int Assoc Study Obes 2001; 25: 622–627.Disclosure of Interests:None declared


2011 ◽  
Vol 35 (8) ◽  
pp. 1071-1078 ◽  
Author(s):  
M Forster ◽  
J L Veerman ◽  
J J Barendregt ◽  
T Vos

2013 ◽  
Vol 21 ◽  
pp. S85
Author(s):  
P. DeVita ◽  
D. Beavers ◽  
R.F. Loeser ◽  
D.J. Hunter ◽  
C. Legault ◽  
...  

2014 ◽  
Vol 2 (1) ◽  
Author(s):  
Sixten Borg ◽  
Ingmar Näslund ◽  
Ulf Persson ◽  
Knut Ödegaard

Background:The rising trend in the prevalence of obesity has during the past decades become a major public health concern in many countries, as obesity may lead to comorbidities and death. A frequent used marker for obesity is the Body Mass Index (BMI). The cost of treatment for obesity related diseases has become a heavy burden on national health care budget in many countries. While diet and exercise are the cornerstones of weight management, pharmaco­therapy is often needed to achieve and maintain desired weight loss.  In some cases of extreme obesity, bariatric surgery may be recommended. It is expected to increase by 50% in Sweden.Objective: The overall objective was to develop a cost-effectiveness model using the best available evidence to assess the cost-effectiveness of gastric bypass (GBP) surgical treatments for obesity in adult patients, in comparison with conventional treatment (CT), in Sweden from a healthcare perspective. With the model we also seeked to identify the lower cut-off point using BMI criteria, for the surgical intervention to be cost-effective. Methods:A micro-simulation model with an underlying Markov methodology was developed, that simulates individual patients. It simulates the outcomes of the patients in terms of treatment costs, life years, and quality adjusted life years (QALY) over his/her remaining lifetime. The costs are presented in SEK in the year 2006 price level (1 SEK ≈ 0.11 EUR ≈ 0.14 USD).Results: We estimated that the incremental cost per QALY gained will not exceed SEK 33,000 per QALY in patients with BMI < 35. In patients with BMI > 35 kg/m2, gastric bypass surgery has lower costs compared to conventional treatment. Conclusion: Gastric bypass surgery is a cost-effective intervention compared to conventional treatment consisting of watchful waiting, diet and exercise.


1999 ◽  
Vol 2 (5) ◽  
pp. 369
Author(s):  
AJ Palmer ◽  
PP Sendi ◽  
V Gozzoli ◽  
A Brandt ◽  
GA Spinas

JAMA ◽  
2016 ◽  
Vol 315 (23) ◽  
pp. 2619 ◽  
Author(s):  
Dalane W. Kitzman ◽  
Mark J. Haykowsky ◽  
William Kraus

2015 ◽  
Vol 97 (10) ◽  
pp. 807-817 ◽  
Author(s):  
Joseph F. Konopka ◽  
Andreas H. Gomoll ◽  
Thomas S. Thornhill ◽  
Jeffrey N. Katz ◽  
Elena Losina

2018 ◽  
Vol 9 (2) ◽  
pp. 227-235 ◽  
Author(s):  
Shannon L Mihalko ◽  
Phillip Cox ◽  
Daniel P Beavers ◽  
Gary D Miller ◽  
Barbara J Nicklas ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-11 ◽  
Author(s):  
Bin Wan ◽  
Nan Fang ◽  
Wei Guan ◽  
Haixia Ding ◽  
Ying Wang ◽  
...  

Aims/Introduction. The present study estimated the cost-effectiveness of bariatric surgery versus medication therapy for the management of recently diagnosed type 2 diabetes mellitus (T2DM) in obese patients from a Chinese health insurance payer perspective. Materials and Methods. A Markov model was established to compare the 40-year time costs and quality-adjusted life-years (QALYs) between bariatric surgery and medication therapy. The health-care costs in the bariatric surgery group, proportion of patients in each group with remission of diabetes, and state transition probabilities were calculated based on observed resource utilization from the hospital information system (HIS). The corresponding costs in the medication therapy group were derived from the medical insurance database. QALYs were estimated from previous literature. Costs and outcomes were discounted 5% annually. Results. In the base case analysis, bariatric surgery was more effective and less costly than medication therapy. Over a 40-year time horizon, the mean discounted costs were 86,366.55 RMB per surgical therapy patient and 113,235.94 CNY per medication therapy patient. The surgical and medication therapy patients lived 13.46 and 10.95 discounted QALYs, respectively. Bariatric surgery was associated with a mean health-care savings of 26,869.39 CNY and 2.51 additional QALYs per patient compared to medication therapy. Uncertainty around the parameter values was tested comprehensively in sensitivity analyses, and the results were robust. Conclusions. Bariatric surgery is a dominant intervention over a 40-year time horizon, which leads to significant cost savings to the health insurance payer and increases in health benefits for the management of recently diagnosed T2DM in obese patients in China.


Sign in / Sign up

Export Citation Format

Share Document